Warner Chilcott competitors

Zippia score 4.2

Warner Chilcott main competitors are Boehringer Ingelheim, Gilead Sciences, and Janssen.

Competitor Summary. See how Warner Chilcott compares to its main competitors:

Johnson & Johnson has the most employees (134,500).
Employees at Boehringer Ingelheim earn more than most of the competitors, with an average yearly salary of $106,981.

Work at Warner Chilcott?

Share your experience

Warner Chilcott vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Warner Chilcott	1968	4.2	Rockaway, NJ	1	$105.1M	3,000
Vertex Pharmaceuticals	1989	4.6	Boston, MA	5	$11.0B	3,400
Forest Laboratories	1954	4.8	New York, NY	1	$3.6B	6,200
Merck	1891	4.6	Kenilworth, NJ	31	$64.2B	74,000
Johnson & Johnson	1886	4.7	New Brunswick, NJ	26	$88.8B	134,500
Sanofi Genzyme	1981	4.8	Cambridge, MA	1	$4.6B	12,000
Regeneron	1988	4.9	Tarrytown, NY	7	$14.2B	9,123
Amgen	1980	4.8	Thousand Oaks, CA	9	$33.4B	22,000
Seagen	1997	4.7	Bothell, WA	3	$2.0B	900
Gilead Sciences	1987	4.5	Foster City, CA	9	$28.8B	11,800
PDI	1987	4.4	Parsippany-Troy Hills, NJ	1	$22.0M	350
Endo Pharmaceuticals Inc	1997	4.7	Malvern, PA	3	$2.6B	385
Daiichi Sankyo	2005	4.8	Parsippany-Troy Hills, NJ	2	$9.0B	15,348
Organon	-	4.5	-	-	$6.4B	158
Janssen	1953	4.9	Raritan, NJ	4	$601.4M	1,500
Forest Pharmaceuticals Inc	1954	4.2	Saint Louis, MO	1	$40.0M	50
Depomed	1995	4.0	Newark, CA	2	$342.7M	494
Takeda Pharmaceuticals U.S.A., Inc.	1998	4.7	Deerfield, IL	14	$12.1B	30,481
Noven	1987	4.6	Miami, FL	2	$520.0M	586
Boehringer Ingelheim	1984	4.6	Ridgefield, CT	5	$17.2B	52,391
Monarch Pharmaceuticals, Inc	1994	4.1	Bristol, TN	1	$1.7B	3,381

Rate how well Warner Chilcott differentiates itself from its competitors.

Warner Chilcott salaries vs competitors

Among Warner Chilcott competitors, employees at Boehringer Ingelheim earn the most with an average yearly salary of $106,981.

Compare Warner Chilcott salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Warner Chilcott	$92,301	$44.38	-
Vertex Pharmaceuticals	$95,952	$46.13	-
Forest Laboratories	$91,901	$44.18	-
Merck	$90,328	$43.43	-
Johnson & Johnson	$76,686	$36.87	-
Sanofi Genzyme	$84,495	$40.62	-

Compare Warner Chilcott job title salaries vs competitors

Company	Highest salary	Hourly salary
Warner Chilcott	$87,334	$41.99
Boehringer Ingelheim	$115,703	$55.63
Janssen	$111,648	$53.68
Amgen	$101,179	$48.64
Regeneron	$98,870	$47.53
Merck	$98,284	$47.25
Vertex Pharmaceuticals	$95,934	$46.12
Sanofi Genzyme	$94,952	$45.65
Gilead Sciences	$94,165	$45.27
Forest Laboratories	$92,036	$44.25
Johnson & Johnson	$88,452	$42.53
Forest Pharmaceuticals Inc	$78,691	$37.83
Takeda Pharmaceuticals U.S.A., Inc.	$77,428	$37.23
Endo Pharmaceuticals Inc	$75,892	$36.49
Organon	$75,535	$36.32
Daiichi Sankyo	$75,293	$36.20
PDI	$74,441	$35.79
Depomed	$73,246	$35.21
Noven	$72,879	$35.04
Monarch Pharmaceuticals, Inc	$70,619	$33.95

Do you work at Warner Chilcott?

Does Warner Chilcott effectively differentiate itself from competitors?

Warner Chilcott jobs

Warner Chilcott demographics vs competitors

Compare gender at Warner Chilcott vs competitors

Job title	Male	Female
Merck	54%	46%
Regeneron	54%	46%
Gilead Sciences	56%	44%
Amgen	57%	43%
Johnson & Johnson	58%	42%
Warner Chilcott	-	-

Male

Female

100%

75%

50%

25%

25%

50%

75%

100%

Compare race at Warner Chilcott vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Amgen	49%	24%	7%	15%	5%	9.7
Gilead Sciences	44%	20%	8%	23%	6%	9.8
Johnson & Johnson	54%	16%	10%	15%	4%	9.8
Merck	56%	16%	10%	14%	4%	9.8
Regeneron	54%	15%	10%	17%	4%	9.8
Vertex Pharmaceuticals	56%	14%	7%	17%	6%	9.7

Warner Chilcott and similar companies CEOs

CEOBio

Robert A. Bradway

Amgen

Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.

Dan Peisert

Daniel O’Day

Joaquin Duato

Robert M. Davis

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Roger D. Dansey

Seagen

Reshma Kewalramani M.d

Vertex Pharmaceuticals

Reshma Kewalramani (born 1973), is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.

Ken Keller

Daiichi Sankyo

Paul Campanelli

Endo Pharmaceuticals Inc

Paul Hudson

Sanofi Genzyme